Literature DB >> 20630144

Human activities predominate in determining changing incidence of tick-borne encephalitis in Europe.

S E Randolph1.   

Abstract

Explanations for the dynamics of tick-borne disease systems usually focus on changes in the transmission potential in natural enzootic cycles. These are undoubtedly important, but recent analyses reveal that they may not be quantitatively the most significant side of the interaction between infected ticks and humans. Variation in human activities that may impact inadvertently but positively on both the enzootic cycles and the degree of human exposure to those cycles, provide more robust explanations for recent upsurges in tick-borne encephalitis in Europe. This can account for long-term increases in incidence that coincided with post-soviet political independence, for small-scales spatial variation in incidence within a country, and for short-scale fluctuations such as annual spikes in incidence. The patterns of relevant human activities, typically those related to the use of forest resources, are evidently driven and/or constrained by the cultural and socio-economic circumstances of each population, resulting in contrasting national epidemiological outcomes.

Entities:  

Mesh:

Year:  2010        PMID: 20630144     DOI: 10.2807/ese.15.27.19606-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  27 in total

1.  Habitat and occurrence of ixodid ticks in the Liguria region, northwest Italy.

Authors:  Leonardo A Ceballos; Maria D Pintore; Laura Tomassone; Alessandra Pautasso; Donal Bisanzio; Walter Mignone; Cristina Casalone; Alessandro Mannelli
Journal:  Exp Appl Acarol       Date:  2014-03-30       Impact factor: 2.132

Review 2.  Tick-borne encephalitis: A review of epidemiology, clinical characteristics, and management.

Authors:  Petra Bogovic; Franc Strle
Journal:  World J Clin Cases       Date:  2015-05-16       Impact factor: 1.337

3.  Tick-borne encephalitis in children and adolescents in the Czech Republic between 1960 and 2007.

Authors:  Petr Pazdiora; Věra Štruncová; Miroslava Švecová
Journal:  World J Pediatr       Date:  2012-11-15       Impact factor: 2.764

Review 4.  Drivers, dynamics, and control of emerging vector-borne zoonotic diseases.

Authors:  A Marm Kilpatrick; Sarah E Randolph
Journal:  Lancet       Date:  2012-12-01       Impact factor: 79.321

5.  De novo Ixodes ricinus salivary gland transcriptome analysis using two next-generation sequencing methodologies.

Authors:  Alexandra Schwarz; Björn M von Reumont; Jan Erhart; Andrezza C Chagas; José M C Ribeiro; Michalis Kotsyfakis
Journal:  FASEB J       Date:  2013-08-20       Impact factor: 5.191

6.  A national case-control study identifies human socio-economic status and activities as risk factors for tick-borne encephalitis in Poland.

Authors:  Pawel Stefanoff; Magdalena Rosinska; Steven Samuels; Dennis J White; Dale L Morse; Sarah E Randolph
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

7.  Economic downturn results in tick-borne disease upsurge.

Authors:  Elinor R Godfrey; Sarah E Randolph
Journal:  Parasit Vectors       Date:  2011-03-15       Impact factor: 3.876

8.  The impact of climate change on the expansion of Ixodes persulcatus habitat and the incidence of tick-borne encephalitis in the north of European Russia.

Authors:  Nikolay K Tokarevich; Andrey A Tronin; Olga V Blinova; Roman V Buzinov; Vitaliy P Boltenkov; Elena D Yurasova; Jo Nurse
Journal:  Glob Health Action       Date:  2011-10-21       Impact factor: 2.640

9.  Using the gravity model to estimate the spatial spread of vector-borne diseases.

Authors:  José Miguel Barrios; Willem W Verstraeten; Piet Maes; Jean-Marie Aerts; Jamshid Farifteh; Pol Coppin
Journal:  Int J Environ Res Public Health       Date:  2012-11-30       Impact factor: 3.390

10.  Feeding patterns of potential West Nile virus vectors in south-west Spain.

Authors:  Joaquín Muñoz; Santiago Ruiz; Ramón Soriguer; Miguel Alcaide; Duarte S Viana; David Roiz; Ana Vázquez; Jordi Figuerola
Journal:  PLoS One       Date:  2012-06-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.